Big Pharma: The Global Effect


In this piece for Vision Magazine, Danit Felber details the U.S. pharmaceutical industry’s efforts to stomp out foreign competition.

“What does this mean practically? A nonprofit largely funded by the pharmaceutical lobby waged a war against a bill that could have increased competition for the pharmaceutical companies, driving down their prices (and profits). The bill would have also needed to be passed by the U.S. Congress, the large majority of which received campaign contributions from the lobbyists (nine out of ten members of the U.S. House of Representatives and all but three of America’s 100 senators). Practically speaking, this means that these players – all of whom are theoretically supposed to be looking out for the welfare of the American people – are putting personal gain over the health and even lives of U.S. citizens.”


  1. Pharma-psychiatry is resurgent in the UK as well. Dr Ed Bullmore FRCPsych is a Professor at Cambridge University and a leading ‘immuno-psychiatrist’. The UK Amazon ‘About the Author’ for his new book ‘The Inflamed Mind’ fails to mention that he has worked half-time for GlaxoSmithKilne (GSK – the makers of Paxil and Wellbutrin) since 2005:

    Amazon UK have not published my 2-star critical review, more than three days after I submitted it. In that time, two anonymous five-star reviews have appeared.

    In my Blog review (900 words) I critique the book as ‘could have been written by a drug rep’ (pharmaceutical company representative). If ‘immuno-psychiatry’ is really valid then cheap generic anti-inflammatories such as ibuprofen should be trialled first. Bullmore and GSK probably want to bring new patented drugs, possibly dangerous ones, onto market:

    Report comment